Article

A gene therapy may begin with an elegant idea: deliver a genetic instruction to the right cells and change how they behave. Yet between that idea and a treatment lies an enormous manufacturing challenge. ...

What if scientists could control the activity of cells using nothing more than pulses of light? What sounds like science fiction has become one of the most influential technologies in modern biology. Earlier this ...

Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek out and ...

What if one of the biggest obstacles in gene therapy could be solved by borrowing a concept from everyday life? Just as Velcro joins two separate pieces together to create a strong and functional ...

How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ...

On the 2nd of June 2026, the GeneH Consortium met together in Ljubljana for their yearly meeting and on the 3rd the consortium organized together with the Center for Functional Genomics and BioChips (CFGBC), ...

In our latest edition of the CTGCT Science Talks webinar series we had Dr. Thomas Fox, a clinician-scientist whose work bridges the gap between the clinical-laboratory interface working across Harvard Medical School and the ...

As part of our efforts towards the sustainability of the CTGCT and with the goal in mind to develop new gene and cell therapies for cancer and rare diseases, our team members are applying ...

From October 15th to 17th, our colleague Vesna Merc joined colleagues and leaders from other Centres of Excellence across Europe for the 4th Teaming Club Conference. Hosted by BIOPOLIS, Biodiversity and Genetic Resources Research ...

In recent decades, the medical toolbox has expanded dramatically. While traditional medicine relied on synthetic drugs (small molecules interacting with specific pathways) and later biologicals like antibodies, we have now entered the era of ...